These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18069155)

  • 1. Human papillomavirus.
    Highleyman L
    BETA; 2007; 19(4):35-9. PubMed ID: 18069155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papilloma virus: diagnostic, treatment and preventive issues.
    Christopoulos P; Deligeoroglou E; Papadias K; Creatsas G
    Akush Ginekol (Sofiia); 2008; 47(1):35-8. PubMed ID: 18642576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
    Harper DM
    Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus vaccines six years after approval.
    Shaw AR
    Annu Rev Med; 2013; 64():91-100. PubMed ID: 23190152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women.
    Viscidi RP; Snyder B; Cu-Uvin S; Hogan JW; Clayman B; Klein RS; Sobel J; Shah KV
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):283-8. PubMed ID: 15668510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Clayman B; Fox K; Massad LS; Cu-Uvin S; Shah KV; Anastos KM; Squires KE; Duerr A; Jamieson DJ; Burk RD; Klein RS; Minkoff H; Palefsky J; Strickler H; Schuman P; Piessens E; Miotti P
    J Infect Dis; 2003 Jan; 187(2):194-205. PubMed ID: 12552444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Getting to know human papillomavirus (HPV) and the HPV vaccines.
    Smith GD; Travis L
    J Am Osteopath Assoc; 2011 Mar; 111(3 Suppl 2):S29-34. PubMed ID: 21415377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of intermediate-risk human papillomavirus infection in uterine cervices of Kenyan women infected with human immunodeficiency virus.
    Rahman M; Sasagawa T; Yamada R; Kingoro A; Ichimura H; Makinoda S
    J Med Virol; 2011 Nov; 83(11):1988-96. PubMed ID: 21915875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and genotype characterization of human papillomaviruses among HIV-seropositive in Ouagadougou, Burkina Faso.
    Djigma FW; Ouédraogo C; Karou DS; Sagna T; Bisseye C; Zeba M; Ouermi D; Gnoula C; Pietra V; Ghilat-Avoid-Belem NW; Sanogo K; Sempore J; Pignatelli S; Ferri AM; Nikiema JB; Simpore J
    Acta Trop; 2011 Mar; 117(3):202-6. PubMed ID: 21167118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV vaccine update: new indications and controversies.
    Mendoza N; Hernandez PO; Tyring SK
    Skin Therapy Lett; 2011 Sep; 16(8):1-3. PubMed ID: 22089414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives for the development of human papillomavirus vaccines and immunotherapy.
    Bermúdez-Humarán LG; Langella P
    Expert Rev Vaccines; 2010 Jan; 9(1):35-44. PubMed ID: 20021304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study.
    Dartell M; Rasch V; Kahesa C; Mwaiselage J; Ngoma T; Junge J; Gernow A; Ejlersen SF; Munk C; Iftner T; Kjaer SK
    Sex Transm Dis; 2012 Mar; 39(3):201-8. PubMed ID: 22337107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus vaccines in HIV-positive men and women.
    De Vuyst H; Franceschi S
    Curr Opin Oncol; 2007 Sep; 19(5):470-5. PubMed ID: 17762573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of human papilloma virus testing in cervical cancer prevention.
    Fey MC; Beal MW
    J Midwifery Womens Health; 2004; 49(1):4-13. PubMed ID: 14710135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus (HPV) vaccines: a Canadian update.
    Foerster V; Murtagh J
    Issues Emerg Health Technol; 2007 Dec; (109):1-8. PubMed ID: 18062141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening: from the Papanicolaou smear to the vaccine era.
    Crum CP; Abbott DW; Quade BJ
    J Clin Oncol; 2003 May; 21(10 Suppl):224s-230s. PubMed ID: 12743139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization.
    Bollen LJ; Chuachoowong R; Kilmarx PH; Mock PA; Culnane M; Skunodom N; Chaowanachan T; Jetswang B; Neeyapun K; Asavapiriyanont S; Roongpisuthipong A; Wright TC; Tappero JW
    Sex Transm Dis; 2006 Apr; 33(4):259-64. PubMed ID: 16452834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of human papillomavirus in the malignant transformation of cervix epithelial cells and the importance of vaccination against this virus.
    Ciesielska U; Nowińska K; Podhorska-Okołów M; Dziegiel P
    Adv Clin Exp Med; 2012; 21(2):235-44. PubMed ID: 23214288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.